| Title | Author(s) | Issue date | ???itemlist.??? |
| Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) study | Aravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A. | 24-Nov-2015 | - |
| Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) study | Aravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A. | 24-Nov-2015 | - |
| CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group | Economopoulos, T.; Psyrri, A.; Dimopoulos, M. A.; Kalogera-Fountzila, A.; Pavlidis, N.; Tsatalas, C.; Nikolaides, C.; Mellou, S.; Xiros, N.; Fountzilas, G. | 24-Nov-2015 | - |
| Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group | Pectasides, D.; Samantas, E.; Fountzilas, G.; Briasoulis, E.; Kosmidis, P.; Skarlos, D.; Dimopoulos, M. A.; Kalofonos, H. P.; Economopoulos, T.; Syrigos, K. | 24-Nov-2015 | - |
| Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group | Dimopoulos, M. A.; Bakoyannis, C.; Georgoulias, V.; Papadimitriou, C.; Moulopoulos, L. A.; Deliveliotis, C.; Karayannis, A.; Varkarakis, I.; Aravantinos, G.; Zervas, A.; Pantazopoulos, D.; Fountzilas, G.; Bamias, A.; Kyriakakis, Z.; Anagnostopoulos, A.; Giannopoulos, A.; Kosmidis, P. | 24-Nov-2015 | - |
| Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Papadimitriou, C.; Dafni, U.; Bafaloukos, D.; Skarlos, D.; Moulopoulos, L. A.; Razis, E.; Kalofonos, H. P.; Aravantinos, G.; Briassoulis, E.; Papakostas, P.; Abela, K.; Gogas, E.; Kosmidis, P.; Pavlidis, N.; Dimopoulos, M. A. | 24-Nov-2015 | - |
| Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG) | Pectasides, D.; Papaxoinis, G.; Fountzilas, G.; Aravantinos, G.; Bamias, A.; Pavlidis, N.; Kalofonos, H. P.; Timotheadou, E.; Samantas, E.; Briasoulis, E.; Skarlos, D. V.; Economopoulos, T.; Dimopoulos, M. A. | 24-Nov-2015 | - |
| Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience | Pectasides, D.; Fountzilas, G.; Aravantinos, G.; Bamias, A.; Kalofonos, H. P.; Skarlos, D.; Briasoulis, E.; Konstantara, A.; Economopoulos, T.; Dimopoulos, M. A. | 24-Nov-2015 | - |
| Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study | Koutras, A. K.; Kalogeras, K. T.; Dimopoulos, M. A.; Wirtz, R. M.; Dafni, U.; Briasoulis, E.; Pectasides, D.; Gogas, H.; Christodoulou, C.; Aravantinos, G.; Zografos, G.; Timotheadou, E.; Papakostas, P.; Linardou, H.; Razis, E.; Economopoulos, T.; Kalofonos, H. P.; Fountzilas, G. | 24-Nov-2015 | - |
| Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy | Kostopoulos, I.; Arapantoni-Dadioti, P.; Gogas, H.; Papadopoulos, S.; Malamou-Mitsi, V.; Scopa, C. D.; Markaki, S.; Karagianni, E.; Kyriakou, V.; Margariti, A.; Kyrkou, E.; Pavlakis, K.; Zaramboukas, T.; Skordalaki, A.; Bourli, A.; Markopoulos, C.; Pectasides, D.; Dimopoulos, M. A.; Skarlos, D.; Fountzilas, G. | 24-Nov-2015 | - |
| Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study | Dimopoulos, M. A.; Papadopoulou, M.; Andreopoulou, E.; Papadimitriou, C.; Pavlidis, N.; Aravantinos, G.; Aspropotamitis, A.; Anagnostopoulos, A.; Fountzilas, G.; Michalas, S.; Pectacides, D. | 24-Nov-2015 | - |
| First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study | Pectasides, D.; Dimopoulos, M. A.; Aravantinos, G.; Kalophonos, H. P.; Papacostas, P.; Briasoulis, E.; Cogas, E.; Papadimitriou, C.; Skarlos, D.; Kosmidis, P.; Fountzilas, G. | 24-Nov-2015 | - |
| G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant setting | Briasoulis, E.; Andreopoulou, E.; Tolis, C. F.; Bairaktari, E.; Katsaraki, A.; Dimopoulos, M. A.; Fountzilas, G.; Seferiadis, C.; Pavlidis, N. | 24-Nov-2015 | - |
| Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group | Nicolaides, C.; Dimopoulos, M. A.; Samantas, E.; Bafaloukos, D.; Kalofonos, C.; Fountzilas, G.; Razi, E.; Kosmidis, P.; Pavlidis, N. | 24-Nov-2015 | - |
| Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study | Skarlos, D. V.; Kalofonos, H. P.; Fountzilas, G.; Dimopoulos, M. A.; Pavlidis, N.; Razis, E.; Economopoulos, T.; Pectasides, D.; Gogas, H.; Kosmidis, P.; Bafaloukos, D.; Klouvas, G.; Kyratzis, G.; Aravantinos, G. | 24-Nov-2015 | - |
| Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer | Aravantinos, G.; Dimopoulos, M. A.; Kosmidis, P.; Bafaloukos, D.; Papadimitriou, C.; Kiamouris, C.; Pavlidis, N.; Sikiotis, K.; Papakostas, P.; Skarlos, D. V. | 24-Nov-2015 | - |
| Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG) | Papaxoinis, G.; Fountzilas, G.; Rontogianni, D.; Dimopoulos, M. A.; Pavlidis, N.; Tsatalas, C.; Pectasides, D.; Xiros, N.; Economopoulos, T. | 24-Nov-2015 | - |
| Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid | Mountzios, G.; Terpos, E.; Syrigos, K.; Papadimitriou, C.; Papadopoulos, G.; Bamias, A.; Mavrikakis, M.; Dimopoulos, M. A. | 24-Nov-2015 | - |
| Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study | Briasoulis, E.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Xiros, N.; Aravantinos, G.; Samantas, E.; Kalofonos, H.; Makatsoris, T.; Mylonakis, N.; Papakostas, P.; Skarlos, D.; Varthalitis, I.; Pavlidis, N. | 24-Nov-2015 | - |
| Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group | Koutras, A. K.; Fountzilas, G.; Dafni, U.; Dimopoulos, M. A.; Pectasides, D.; Klouvas, G.; Papakostas, P.; Kosmidis, P.; Samantas, E.; Gogas, H.; Briasoulis, E.; Vourli, G.; Petsas, T.; Xiros, N.; Kalofonos, H. P. | 24-Nov-2015 | - |
